通过增强FOXO3A无化和降解,TRIM6促进质瘤恶性进展
Jingpeng Guo1, Ji Wang2, Peng Zhang3
1Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China; Department of Neurosurgery, Fuyang People's Hospital, Fuyang, Anhui 236000, China.
三方基因 (TRIM) 6在质瘤中高度表达,并通过破坏FOXO3A的稳定性来促进瘤的进展. 准TRIM6-FOXO3A通路可能为质瘤提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 三方基因 (TRIM) 6 是一种E3泛基因酶,涉及各种癌症.
- 在质瘤进展中TRIM6的作用需要进一步研究.
研究的目的:
- 研究TRIM6在质瘤进展中的作用和机制.
- 探索TRIM6在质瘤患者的预后价值.
主要方法:
- 使用TCGA和CGGA数据库分析TRIM6表达和预后值.
- 在体外测试 (CCK8,殖民地形成,伤口愈合,Transwell) 评估了质瘤细胞的行为.
- 同免疫沉和西部斑点确定了TRIM6-FOXO3A相互作用.
- 在体内异种移植模型中验证了TRIM6对瘤生长的影响.
主要成果:
- 高TRIM6表达与质瘤患者的预后不佳相关.
- 在体外和体内,TRIM6倒置抑制了,而过度表达增强了质瘤细胞的增殖,入侵和迁移.
- TRIM6与FOXO3A直接相互作用,促进其无处不在和降解.
- 通过降低FOXO3A的调节,TRIM6促进质瘤的进展.
结论:
- TRIM6-FOXO3A轴是质瘤进展的关键驱动因素.
- 针对TRIM6-FOXO3A相互作用,为质瘤提供了一个潜在的治疗策略.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
相关概念视频
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
